Special issue: Recent Insights in Chemistry and Technology of Cyclodextrins
International Journal of Molecular Sciences (MDPI) plans a Special Issue: Recent Insights in Chemistry and Technology of Cyclodextrins in connection
A forum for researchers, students and applicants in the field of cyclodextrin technology
International Journal of Molecular Sciences (MDPI) plans a Special Issue: Recent Insights in Chemistry and Technology of Cyclodextrins in connection
Matthieu Sollogoub, professor of Biological and Supramolecular Glycochemistry at Sorbonne University gave a plenary lecture at the 20th International Cyclodextrin
The aim of this study was to evaluate the interaction between catanionic vesicles based on amphiphilic cyclodextrins (ModCBHD) and DNA–Doxorubicin
Nanoparticle-based therapeutics represent potential strategies for treating atherosclerosis; however, the complex plaque microenvironment poses a barrier for nanoparticles to target
Background: A recent survey revealed that extensive off-label use of sugammadex in pediatric anesthesia deserved particular attention. The present study
The purpose of this study was to prepare an adenosine (ADS): β-CD inclusion complex that could be consistently incorporated into
Phytocannabinoids possess anticancer properties, as established in vitro and in vivo. However, they are characterized by high lipophilicity. To improve
A recently published book titled “Applications of Polymer Nanofibers” (Wiley, 2022) contains a chapter on “Electrospun Nanofibers for Drug Delivery
Tetraethylenepentamine-coated β-cyclodextrin (TEPA-BCD) nanoparticles were synthesized, characterized, and evaluated for targeted cell delivery of plasmid DNA and siRNA. The cationic
2-hydroxypropyl-ß-cyclodextrin (kleptose) is used for the treatment of Niemann–Pick disease. Kleptose crosses the blood–brain barrier poorly, in part because of